FDA Warning Letter — Acorda Therapeutics, Inc.

Case 232754 — FEI 3002457563

The FDA took a Warning Letter action against Acorda Therapeutics, Inc. on May 10, 2012 (Pearl River, NY). The action was issued by CDER and concerns drugs products. This facility has 5 or more recent FDA inspections on record.

Action Details

Facility
Acorda Therapeutics, Inc.
Date
May 10, 2012
Fiscal Year
2012
Product Type
Drugs
Center
CDER
Location
Pearl River, NY (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.